Recent innovations include engineering CAR T-cells to overcome the immunosuppressive tumour microenvironment and enhancing ...

If preclinical findings were translated into the clinic, they could shorten the CAR-T generation lead time from two weeks to ...

Edgar Lerma, MD, provides insights into the pathophysiology of IgA nephropathy (IgAN) and the therapeutic promise of ...

On track to announce primary endpoint result from ORIGIN 3 trial this quarter (2Q 2025)U.S. FDA BLA submission for accelerated approval planned ...

Giant-cell arteritis is a systemic vasculitis with limited treatment options. The efficacy and safety of upadacitinib — a ...

B7-33, a synthetic analog of relaxin-2, has emerged as a focal point in contemporary scientific research due to its selective ...

In the 2024 update of The Lancet Commission’s position on dementia care, a panel of experts identified 14 modifying risk ...

Can the key to a longer, healthier life be found in your kitchen? As the global population ages, scientists have uncovered ...

Teacher Retirement System of Texas grew its stake in shares of ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 20.4% in the ...

There is growing concern that plastics may also be responsible for significant harm to the earth’s environment and human ...

Researchers are now trying to find something the doctors lack: objective indicators of pain that will enable physicians to ...

All these speak to a gentle, holistic approach—Arialief strives for real healing and not just sedation of nerve signals. As ...